Office of the Registrar or Lobbying of BC

Menus

  • Menus

www.lobbyistsregistrar.bc.ca

  • www.lobbyistsregistrar.bc.ca

Designated Filer menu

  • Registry Search Tools
    • 12-Month Lobbying Activity Search
    • Advanced Registry Search
  • Reporting Tools
    • Recent Registrations
    • Recent Lobbying Activity Reports by Posted Date
    • Government Funding Report
    • Gifts to Public Office Holders Report
    • Listing of All Lobbyists and Senior Officers
    • Listing of Senior Public Officer Holders who are in Lobbying Activity Reports
    • Listing of Organizations Clients and their Direct Interests
  • Lobbying Statistics
    • Active Lobbyists and Registrations by Type
    • Ministries/Provincial Entities in Active Registrations
    • Ministries/Provincial Entities in Lobbying Activity Reports
    • Lobbying Activity Reports by Reporting Period
    • Subject Matter in Active Registrations
    • Subject Matter in Lobbying Activity Reports
    • Intended Outcomes in Active Registrations
    • Intended Outcomes in Lobbying Activity Reports
  • Help
    • LTA Guidance Documents
    • Using the Registry
    • Legislation
    • LTA Frequently Asked Questions
    • Contact Us
  • Sign In

You are here:

  1. Registry Dashboard

 

Subject matter details

Boehringer Ingelheim (Canada) Ltd.


Registration: 9 of 12 (2024-06-10 to 2024-07-03)

Details Regarding the Identified Subject Matter
Specific Topics of Lobbying Communications Intended Outcomes Associated Subject Matters
Advocated for the development of a public/private partnership with government regarding a program to provide a virtual health initiative around heart failure.
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
Health, Information Technology
Arranged a Zoom meeting with Mr. Bob D'Eith, representatives of Boehringer Ingelheim, and me.
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
Health, Information Technology
Arranged a Zoom meeting with Mr. Jagrup Brar, representatives of Boehringer Ingelheim, and me.
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
Health, Information Technology
Arranged a Zoom meeting with Ms. Rachna Singh, representatives of Boehringer Ingelheim, and me.
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
Health, Information Technology
Cancelled a request for a Teams meeting so that Min. Kahlon, DM Bobbi Plecas and Parliamentary Secretary Ms. Brenda Bailey can meet with Ms. Andrea Sambati, CEO, Boehringer Ingelheim to discuss possible partnerships.
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
Health, Information Technology
Contacted Ms. Alysa Huppler-Poliak to request that a Zoom meeting be arranged with Mr. Bob D'Eith, representatives of Boehringer Ingelheim, and me.
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
Health, Information Technology
Contacted Ms. Kiran Sidhu to Arrange a Zoom meeting with Mr. Ravi Kahlon
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
Health
Contacted Ms. Sarina Grewal to confirm a Zoom meeting between Ms. Rachna Singh, representatives of Boehringer Ingelheim, and me.
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
Health, Information Technology
Contacted Ms. Sarina Grewal to request that a Zoom meeting be arranged with Ms. Rachna Singh, representatives of Boehringer Ingelheim, and me.
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
Health, Information Technology
Discussed BI's desire to partner with Government with Mr. Ravi Hahlon
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
Health
Discussed BI's desire to partner with Government with Ms. Rachna Singh.
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
Health
Discusses BI's desire to partner with Government with Mr. Bob D'Eith.
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
Health
Discussions with officials concerning the development of a partnership with government regarding a program to provide virtual health services for chronic disease care.
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
Health
Emailed a request for a Teams meeting so that Min. Rankin and DM Doug Caul may meet with Ms. Andrea Sambati, CEO, Boehringer Ingelheim to discuss possible partnerships.
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
Health, Information Technology
Emailed a request for a Teams meeting so that Mr. Meggs may meet with Ms. Andrea Sambati, CEO, Boehringer Ingelheim to discuss possible partnerships.
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
Health, Information Technology
Had a discussion around how BC PharmaCare will possibly interact with the proposed National PharmaCare program
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
Health, Information Technology
Had a phone call and requested information regarding priority areas of reimbursement for rare disease drugs.
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
Health, Information Technology
Had Zoom meeting with Mr. Garry Begg, representatives pf Boehringer Ingelheim, and me to discuss a possible partnership with government around virtual healthcare
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
Health, Information Technology
Had Zoom meeting with Mr. Jagrup Brar, representatives pf Boehringer Ingelheim, and me to discuss a possible partnership with government around virtual healthcare
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
Health, Information Technology
Requested a Zoom meeting between Mr. Nicholas Simons, representatives of Boehringer Ingelheim, and me.
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
Health, Information Technology
Requested Mr. Begg to organize a Zoom meeting of the Surrey NDP Caucus
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
Health, Information Technology
Sent email requesting proper procedure to request a meeting with MLA Jennifer Rice in her role as Parliamentary Secretary for Rural Health. Emailed a Briefing Note on existing partnerships and projects between Boehringer Ingelheim and the Government of BC, and to advocate for the development of future partnerships and projects.
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
Health, Information Technology
Spoke to and emailed a request for a Teams meeting so that Ms. Isobel Mackenzie may meet with Ms. Andrea Sambati, CEO, Boehringer Ingelheim to discuss possible partnerships.
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
Health, Information Technology
Spoke to and emailed request to meet with DM Tom McCarthy and ADM Jennifer Melles. Emailed a Briefing Note on existing partnerships and projects between Boehringer Ingelheim and the Government of BC, and to advocate for the development of future partnerships and projects.
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
Health, Information Technology
Spoke to Ms. Amna Shah to arrange a conference call between Mr. Garry Begg, representatives from Boehringer Ingelheim, and me.
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
Health, Information Technology
Spoke to Ms. Amna Shah to arrange a conference call between Mr. Garry Begg, representatives from Boehringer Ingelheim, and me.
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
Health, Information Technology
Spoke with Ms. Alysa Huppler-Poliak to confirm a Zoom meeting with Mr. Bob D'Eith, representatives of Boehringer Ingelheim, and me.
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
Health, Information Technology
To advocate for policy development with a focus on health care and public drug program funding
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
Health